Cambridge Nutritional Sciences plc (AIM:CNSL)
1.725
-0.025 (-1.43%)
Jul 31, 2026, 4:05 PM GMT
AIM:CNSL Financials Overview
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue Revenue Growth | 8.06 | 8.33 | 9.77 | 7.55 | 8.54 | 6.82 |
Revenue Growth | -3.25% | -14.77% | 29.53% | -11.63% | 25.28% | -30.58% |
Gross Profit Gross Profit Growth | 5.35 | 5.44 | 6.05 | 3.55 | 5.1 | 4 |
Operating Income Operating Income Growth | -0.54 | -0.4 | -0.54 | -2.72 | -0.59 | -0.47 |
Net Income Net Income Growth | 1.37 | 1.57 | -0.33 | -3.86 | -11.33 | -2.1 |
Earnings Per Share EPS Growth | 0.01 | 0.01 | -0.00 | -0.02 | -0.06 | -0.01 |
EPS Growth | -12.90% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
United Kingdom United Kingdom Growth | 1.7 | 1.65 | 1.53 | 0.98 | 0.47 | 0.4 |
Rest of Europe Rest of Europe Growth | 1.74 | 1.99 | 2.06 | 2.31 | 2.61 | 1.78 |
Americas Americas Growth | 1.42 | 1.48 | 2.36 | - | - | - |
India India Growth | 0.79 | 0.69 | 0.55 | 0.53 | 0.51 | 0.29 |
Africa and The Middle East Africa and The Middle East Growth | 0.53 | 0.61 | 1.04 | 0.56 | 1.21 | 0.64 |
Asia and The Far East Asia and The Far East Growth | - | 1.91 | 2.24 | 1.73 | 1.5 | 2.59 |
Total Total Growth | 8.06 | 8.33 | 9.77 | 7.55 | 8.54 | 6.82 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Investments Cash & Investments Growth | 3.59 | 4.87 | 5.44 | 5.12 | 1.61 | 5.83 |
Total Debt Total Debt Growth | 0.24 | 0.35 | 0.15 | 0.07 | 0.37 | 2.84 |
Net Cash (Debt) Net Cash Growth | 3.36 | 4.52 | 5.3 | 5.04 | 1.24 | 2.98 |
Net Cash Growth | -25.71% | -14.67% | 5.06% | 308.18% | -58.61% | - |
Net Cash Per Share Net Cash Per Share Growth | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -0.27 | -0.06 | 0.61 | -3.15 | -3.23 | -2.42 |
Capital Expenditures CapEx Growth | -0.27 | -0.23 | -0.05 | -0.03 | -0.97 | -1.97 |
Free Cash Flow Free Cash Flow Growth | -0.54 | -0.28 | 0.56 | -3.18 | -4.2 | -4.38 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Gross Margin | 66.44% | 65.32% | 61.86% | 46.98% | 59.75% | 58.63% |
Operating Margin | -6.70% | -4.74% | -5.47% | -35.98% | -6.93% | -6.87% |
Pretax Margin | 16.94% | 18.80% | -7.62% | -43.10% | -11.13% | -8.01% |
Profit Margin | 16.94% | 18.80% | -3.36% | -51.15% | -132.72% | -30.87% |
FCF Margin | -6.71% | -3.38% | 5.72% | -42.10% | -49.15% | -64.32% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
PE Ratio | 3.05 | 4.63 | - | - | - | - |
Forward PE | - | 260.00 | 260.00 | 260.00 | 260.00 | 260.00 |
P/FCF Ratio | - | - | 14.69 | - | - | - |
PS Ratio | 0.52 | 0.87 | 0.84 | 0.98 | 0.82 | 21.56 |